[The status of drug prevention of respiratory distress syndrome in German gynecologic clinics].
375 german departments of obstetrics with a total of 258,348 deliveries answered a questionnaire on the actual standards in obstetrical management for the prevention of neonatal respiratory distress syndrome. On the basis of these extensive data, results could be obtained about the time and the regimen of therapy as well as antenatal diagnostics of lung maturity. Furthermore the results document the treatment of high risk pregnancies like multiple pregnancies, diabetes mellitus, gestosis and PROM.
Knitza
R
R
Frauenklinik im Klinikum Grosshadern, LMU München.
Linke
M
M
Wisser
J
J
Hepp
H
H
D000551:Ambroxol / Q000008:administration & dosage; D001623:Betamethasone / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D005260:Female; D005325:Fetal Organ Maturity / Q000187:drug effects; D005500:Follow-Up Studies; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D008168:Lung / Q000196:embryology; D008775:Methylprednisolone / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D011247:Pregnancy; D012127:Respiratory Distress Syndrome, Newborn / Q000517:prevention & control*
D000551:Ambroxol; D003907:Dexamethasone; D001623:Betamethasone; D011239:Prednisolone; D011241:Prednisone; D008775:Methylprednisolone
Zum Stand der medikamentösen RDS-Prophylaxe an deutschen Frauenkliniken.